Entia: Funding, Investors & Team (Aug 2026)
Entia is a company focused on medical technology, particularly in enhancing availability of blood tests. The company offers two notable products: Aptus, intended for measuring haemoglobin and haematocrit levels, and Affinity, catered to individuals with cancer for easy monitoring of their blood counts from the comfort of their own homes. Comprised of a diverse team of professionals in various disciplines like design, engineering, quality assurance, business development, and innovation, Entia strives to provide comprehensive solutions in its field.
Entia has raised $20.6M across 1 funding round on record, the most recent a Series A of $20.6M announced in Jul 2023.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Entia Company Profile and Key Stats
Latest funding round on record: Jul 2023.
Entia Funding Rounds
Entia Founders and Leadership Team
Contact details for the Entia team: 1 of 1 has an email address on file.
Start 14-day free trial →Entia Funding Compared to Other Health Care Startups
Entia's latest round of $20.6M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Entia in Health Care and London
Companies Similar to Entia
Renata Medical develops purposeful medical devices for unmet pediatric needs.
Leo Cancer Care provides a streamlined and effective treatment method that empowers patients and instills…
Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous…
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
Nebu-Flow is a manufacturer of the next generation of inhaled drugs for patients with respiratory disorders.…
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial…
Innovative medical gadgets are created by Creo Medical Limited, situated in Chepstow, South Wales. With a…
TympaHealth has developed the world's first ear and hearing health assessment system. The Tympa system…
NEX Health Intelligence (NEX) is a health-tech business that develops AI-powered software for hospitals to…
Infex Therapeutics acquire, develop and license drugs to treat pandemic infections.
Asterix Health is the workforce solution for modern healthcare.
Gloucester Rugby is a professional English rugby union club that gives up to date with all the information…
Entia Funding FAQs
What does Entia do?
Entia is a company focused on medical technology, particularly in enhancing availability of blood tests. The company offers two notable products: Aptus, intended for measuring haemoglobin and haematocrit levels, and Affinity, catered to individuals with cancer for easy monitoring of their blood counts from the comfort of their own homes. Comprised of a diverse team of professionals in various disciplines like design, engineering, quality assurance, business development, and innovation, Entia strives to provide comprehensive solutions in its field.
How much funding has Entia raised?
Entia has raised $20.6M across 1 round on record. The most recent is a Series A of $20.6M announced in Jul 2023.
When did Entia last raise funding?
Entia's most recent funding round on record is a Series A of $20.6M, announced in Jul 2023.
Who is the CEO of Entia?
Toby Basey Fisher is listed as CEO at Entia.
Where is Entia headquartered?
Entia is based in London, England, United Kingdom.
How many employees does Entia have?
Entia is in the 11-50 employee band.
How does Entia's funding compare to other Health Care startups?
Entia's latest round of $20.6M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Entia Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Entia is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.